Skandinaviska Enskilda Banken (SEB)’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,700
Closed -$1.19M 761
2025
Q3
$1.19M Sell
20,700
-5,800
-22% -$334K ﹤0.01% 618
2025
Q2
$1.56M Buy
26,500
+23,300
+728% +$1.51M 0.01% 604
2025
Q1
$234K Buy
+3,200
New +$264K ﹤0.01% 736
2022
Q4
Sell
-14,720
Closed -$877K 870
2022
Q3
$877K Sell
14,720
-5,411
-27% -$326K 0.01% 702
2022
Q2
$1.13M Sell
20,131
-9,099
-31% -$598K 0.01% 691
2022
Q1
$2.16M Sell
29,230
-15,612
-35% -$1.09M 0.01% 610
2021
Q4
$3.25M Buy
44,842
+308
+0.7% +$22.4K 0.02% 524
2021
Q3
$3.41M Buy
44,534
+151
+0.3% +$12.1K 0.02% 510
2021
Q2
$3.44M Buy
44,383
+1,066
+2% +$75.8K 0.02% 513
2021
Q1
$2.67M Buy
43,317
+6,247
+17% +$396K 0.02% 567
2020
Q4
$2.42M Buy
37,070
+4,832
+15% +$278K 0.02% 580
2020
Q3
$1.6M Buy
32,238
+9,674
+43% +$499K 0.01% 632
2020
Q2
$1.08M Buy
22,564
+1,540
+7% +$74.3K 0.01% 714
2020
Q1
$894K Sell
21,024
-4,206
-17% -$208K 0.01% 665
2019
Q4
$1.49M Buy
25,230
+49
+0.2% +$2.66K 0.01% 633
2019
Q3
$1.29M Buy
+25,181
New +$1.2M 0.01% 638

Other funds holding GMED

Skandinaviska Enskilda Banken (SEB)'s GMED Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 20,700 shares — an estimated $1.19M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in GMED in Q3 2019 and held it in 16 quarters. The position peaked at $3.44M in Q2 2021. 563 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 20,700 Globus Medical shares in Q4 2025, an estimated $1.19M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Globus Medical in Q3 2019 and held it in 16 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Globus Medical position peaked at $3.44M in Q2 2021.
  • 563 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.